1. Home
  2. XWEL vs INM Comparison

XWEL vs INM Comparison

Compare XWEL & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XWEL

XWELL Inc.

HOLD

Current Price

$0.93

Market Cap

9.2M

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.46

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XWEL
INM
Founded
2006
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
7.7M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
XWEL
INM
Price
$0.93
$1.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.2K
806.6K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,210,000.00
$4,942,633.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.50
52 Week Low
$0.26
$0.58
52 Week High
$2.20
$2.50

Technical Indicators

Market Signals
Indicator
XWEL
INM
Relative Strength Index (RSI) 42.55 50.01
Support Level $0.85 $1.45
Resistance Level $0.99 $1.52
Average True Range (ATR) 0.07 0.09
MACD -0.00 -0.01
Stochastic Oscillator 11.56 42.67

Price Performance

Historical Comparison
XWEL
INM

About XWEL XWELL Inc.

XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Share on Social Networks: